Copy number alterations define outcome in Philadelphia chromosome-positive acute lymphoblastic leukemia

• Helena Hohtari,
• Niels Pallisgaard,
• Matti Kankainen,
• Pekka Ellonen,
• Oscar Brück,
• Timo Siitonen,
• Marjaana Säily,
• Marjatta Sinisalo,
• Marja Pyörälä,
• Maija Itälä-Remes,
• Perttu Koskenvesa,
• Erkki Elonen,
• Satu Mustjoki,
• Kimmo Porkka

Affiliations

Helena Hohtari

Hematology Research Unit Helsinki, Translational Immunology Research Program, University of Helsinki and Helsinki University Hospital Comprehensive Cancer Center, Helsinki

Niels Pallisgaard

Department of Pathology, Zealand University Hospital, Roskilde

Matti Kankainen

Hematology Research Unit Helsinki, Translational Immunology Research Program, University of Helsinki and Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland; Laboratory of Genetics, HUS Diagnostic Center, Hospital District of Helsinki and Uusimaa (HUS), Helsinki, Finland; Medical and Clinical Genetics, University of Helsinki, Helsinki University Hospital, Helsinki, Finland; iCAN Digital Precision Cancer Medicine Flagship, Helsinki

Pekka Ellonen

Institute for Molecular Medicine Finland, University of Helsinki, Helsinki

Oscar Brück

Hematology Research Unit Helsinki, Translational Immunology Research Program, University of Helsinki and Helsinki University Hospital Comprehensive Cancer Center, Helsinki

Timo Siitonen

Division of Hematology, Oulu University Hospital, Oulu

Marjaana Säily

Division of Hematology, Oulu University Hospital, Oulu

Marjatta Sinisalo

Division of Hematology, Tampere University Hospital, Tampere

Marja Pyörälä

Division of Hematology, Kuopio University Hospital, Kuopio

Maija Itälä-Remes

Division of Hematology, Turku University Hospital, Turku

Perttu Koskenvesa

Division of Hematology, Helsinki University Hospital Comprehensive Cancer Center, Helsinki

Erkki Elonen

Division of Hematology, Helsinki University Hospital Comprehensive Cancer Center, Helsinki

Satu Mustjoki

Hematology Research Unit Helsinki, Translational Immunology Research Program, University of Helsinki and Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland; iCAN Digital Precision Cancer Medicine Flagship, Helsinki, Finland; Department of Clinical Chemistry, University of Helsinki, Helsinki

Kimmo Porkka

Hematology Research Unit Helsinki, Translational Immunology Research Program, University of Helsinki and Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland; iCAN Digital Precision Cancer Medicine Flagship, Helsinki, Finland; Division of Hematology, Helsinki University Hospital Comprehensive Cancer Center, Helsinki